Immune checkpoint inhibitor-induced hyperthyroidism: Incidence, risk factors, and clinical outcomes in a real-world cohort study
{{output}}
BackgroundHyperthyroidism is an immune-related adverse event associated with ICI use. Its underlying risk factors, progression to thyroiditis, and impact on patient outcomes remain less understood.MethodsData were obtained from the TriNetX network for patients... ...
